SCHEMBL7533486

SCHEMBL7533486

N#Cc1cccc(C(Cc2ccccc2)C(=O)Nc2ccc(C(=O)N3CCCC3)c(Br)c2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.43
CCKBR P32239 1/20 0.42
FAAH O00519 1/20 0.40
LMNA P02545 1/20 0.39
MET P08581 2/20 0.39
CCR3 P51677 2/20 0.39
HDAC3 O15379 1/20 0.39
HDAC4 P56524 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
CTSL P07711 1/20 0.39
CTSK P43235 1/20 0.39
FPR2 P25090 2/20 0.38
DPP7 Q9UHL4 1/20 0.38
F10 P00742 1/20 0.38
PRSS1 P07477 1/20 0.38
ALDH1A1 P00352 2/20 0.38
CYP3A4 P08684 2/20 0.38
CYP2C19 P33261 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7114855 0.84 F10 (0.53) SMN1; SMN2F10PRSS1KMT2A
Hydrochloric Acid SCHEMBL7120706 0.83 F10 (0.52) SMN1; SMN2F10PRSS1KMT2A
SCHEMBL7122980 0.80 LMNA (0.53) CCKBRFAAHLMNAMETDPP7
SCHEMBL2997880 0.77 F10 (0.47) SMN1; SMN2F10PRSS1KMT2A
Hydrochloric Acid SCHEMBL7526464 0.76 F10 (0.46) SMN1; SMN2F10PRSS1KMT2A
SCHEMBL7155087 0.73 F10 (0.47) SMN1; SMN2F10PRSS1ALDH1A1KMT2A
SCHEMBL7535081 0.73 CCKBR (0.44) CCKBRDPP7F10PRSS1ALDH1A1
Hydrochloric Acid SCHEMBL7528031 0.73 F10 (0.46) SMN1; SMN2F10PRSS1ALDH1A1KMT2A
SCHEMBL7113075 0.72 MET (0.46) LMNAMETALDH1A1
SCHEMBL867391 0.68 EPHX1 (0.65) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020151595-A1 Carboxylic acid amides having antithrombotic activity BOEHRINGER INGELHEIM PHARMA KG (DE) 2002-10-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020151595-A1 Carboxylic acid amides having antithrombotic activity SERPINC1, TFPI, F2 SMN1; SMN2 2130/4885CCKBR 1107/4885FAAH 73/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.